FORA Capital’s Genmab GMAB Stock Holding History

FORA Capital’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-10,947	Closed	-$413K	–	457
2023 Q1	$413K	Sell	10,947 -4,169	-28%	-$160K	0.04%	385
2022 Q4	$641K	Buy	+15,116	New	+$623K	0.1%	234
2021 Q3	–	Sell	-2,580	Closed	-$105K	–	550
2021 Q2	$105K	Buy	+2,580	New	+$99.6K	0.02%	582
2021 Q1	–	Sell	-7,274	Closed	-$296K	–	891
2020 Q4	$296K	Buy	7,274 +5,691	+360%	+$213K	0.05%	418
2020 Q3	$58K	Sell	1,583 -9,129	-85%	-$330K	0.04%	415
2020 Q2	$363K	Buy	+10,712	New	+$292K	0.12%	218

Other funds holding GMAB

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

FORA Capital's GMAB Position: Q2 2023 in Review

FORA Capital sold out of Genmab (GMAB) in Q2 2023, closing a stake of 10,947 shares — an estimated $413K sold.

FORA Capital first reported a position in GMAB in Q2 2020 and held it in 6 quarters. The position peaked at $641K in Q4 2022. 213 funds tracked by Wall St. Rank hold GMAB as of Q2 2023.

FORA Capital reported no remaining Genmab position as of Q2 2023 after selling out during the quarter.
FORA Capital sold 10,947 Genmab shares in Q2 2023, an estimated $413K.
FORA Capital first reported a position in Genmab in Q2 2020 and held it in 6 quarters.
FORA Capital's Genmab position peaked at $641K in Q4 2022.
213 funds tracked by Wall St. Rank held Genmab as of Q2 2023.

Based on FORA Capital's 13F filing for Q2 2023, filed 11 Aug 2023.